Literature DB >> 25088765

Human papilloma virions in the laboratory.

Eileen F Dunne1, Lauri E Markowitz1, La'shan D Taylor2, Elizabeth R Unger3, Cosette M Wheeler4.   

Abstract

Carcinogenic human papillomaviruses (HPV) can cause cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers. Non-carcinogenic HPVs can cause anogenital warts and recurrent respiratory papillomatosis. Currently, few research laboratories propagate, isolate or generate papilloma virions. However, there have been questions about potential exposure and risk in this setting. In this brief note, we discuss the use of wild type and laboratory-generated virions in research laboratories, potential routes of laboratory exposure, and considerations for HPV vaccination of laboratory personnel.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV; HPV vaccines; Human papillomavirus; Laboratory safety

Mesh:

Substances:

Year:  2014        PMID: 25088765      PMCID: PMC4277695          DOI: 10.1016/j.jcv.2014.06.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  22 in total

1.  Human papillomavirus type 45 propagation, infection, and neutralization.

Authors:  Margaret E McLaughlin-Drubin; Susan Wilson; Brian Mullikin; JoAnn Suzich; Craig Meyers
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

2.  Papillomavirus particles assembled in 293TT cells are infectious in vivo.

Authors:  Timothy D Culp; Nancy M Cladel; Karla K Balogh; Lynn R Budgeon; Andres F Mejia; Neil D Christensen
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.

Authors:  C Meyers; T J Mayer; M A Ozbun
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants.

Authors:  Jordan Meyers; Eric Ryndock; Michael J Conway; Craig Meyers; Richard Robison
Journal:  J Antimicrob Chemother       Date:  2014-02-04       Impact factor: 5.790

5.  Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.

Authors:  Dohun Pyeon; Paul F Lambert; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

6.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

7.  Papillomavirus is resistant to desiccation.

Authors:  R B Roden; D R Lowy; J T Schiller
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

8.  Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections.

Authors:  A Ferenczy; C Bergeron; R M Richart
Journal:  Obstet Gynecol       Date:  1989-12       Impact factor: 7.661

9.  Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures.

Authors:  L Fang; C Meyers; L R Budgeon; M K Howett
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

10.  Human papillomavirus type 16 alters human epithelial cell differentiation in vitro.

Authors:  D J McCance; R Kopan; E Fuchs; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.